|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
144,920,000 |
Market
Cap: |
29.90(B) |
Last
Volume: |
2,928,054 |
Avg
Vol: |
719,313 |
52
Week Range: |
$134.65 - $225.35 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 400 MIDCAP |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 516 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile ResMed is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep-disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Co. operates in two segments: Sleep and Respiratory Care, which relates primarily to the sale of its products that are therapy-based equipment; and Software as a Service, which relates to the provision of software access with ongoing support and maintenance services as well as services such as training and consulting.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
28,909 |
40,044 |
82,722 |
295,486 |
Total Sell Value |
$6,189,714 |
$8,221,798 |
$15,877,792 |
$63,528,191 |
Total People Sold |
5 |
6 |
9 |
11 |
Total Sell Transactions |
6 |
8 |
25 |
75 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2019-07-15 |
4 |
AS |
$124.50 |
$100,098 |
I/I |
(804) |
149,813 |
|
- |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2019-07-15 |
4 |
AS |
$124.50 |
$411,722 |
D/D |
(3,307) |
45,414 |
|
- |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2019-07-15 |
4 |
OE |
$43.63 |
$144,284 |
D/D |
3,307 |
48,721 |
|
- |
|
Farrell Michael J. |
Chief Executive Officer |
|
2019-07-08 |
4 |
AS |
$123.76 |
$823,128 |
D/D |
(6,651) |
286,337 |
|
- |
|
Farrell Michael J. |
Chief Executive Officer |
|
2019-07-08 |
4 |
OE |
$43.63 |
$290,183 |
D/D |
6,651 |
292,988 |
|
- |
|
Pendarvis David |
Chief Administrative Officer |
|
2019-07-03 |
4 |
AS |
$123.83 |
$540,887 |
D/D |
(4,367) |
117,883 |
|
- |
|
Pendarvis David |
Chief Administrative Officer |
|
2019-07-03 |
4 |
OE |
$52.02 |
$227,171 |
D/D |
4,367 |
122,250 |
|
- |
|
Hollingshead James |
President, Sleep Business |
|
2019-07-01 |
4 |
AS |
$123.17 |
$197,072 |
D/D |
(1,600) |
77,423 |
|
- |
|
Hollingshead James |
President, Sleep Business |
|
2019-07-01 |
4 |
OE |
$58.24 |
$46,592 |
D/D |
800 |
78,223 |
|
- |
|
Sandercock Brett |
Chief Financial Officer |
|
2019-07-01 |
4 |
AS |
$123.17 |
$369,510 |
D/D |
(3,000) |
76,514 |
|
- |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2019-06-17 |
4 |
AS |
$118.44 |
$100,319 |
I/I |
(847) |
150,617 |
|
- |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2019-06-17 |
4 |
AS |
$118.44 |
$391,681 |
D/D |
(3,307) |
45,414 |
|
- |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2019-06-17 |
4 |
OE |
$43.63 |
$144,284 |
D/D |
3,307 |
48,721 |
|
- |
|
Farrell Michael J. |
Chief Executive Officer |
|
2019-06-10 |
4 |
AS |
$117.56 |
$785,862 |
D/D |
(6,651) |
286,337 |
|
- |
|
Farrell Michael J. |
Chief Executive Officer |
|
2019-06-10 |
4 |
OE |
$43.63 |
$290,183 |
D/D |
6,651 |
292,988 |
|
- |
|
Hollingshead James |
President, Sleep Business |
|
2019-06-03 |
4 |
AS |
$114.01 |
$182,416 |
D/D |
(1,600) |
78,223 |
|
- |
|
Hollingshead James |
President, Sleep Business |
|
2019-06-03 |
4 |
OE |
$58.24 |
$46,592 |
D/D |
800 |
79,823 |
|
- |
|
Pendarvis David |
Chief Administrative Officer |
|
2019-06-03 |
4 |
AS |
$114.01 |
$497,882 |
D/D |
(4,367) |
117,883 |
|
- |
|
Pendarvis David |
Chief Administrative Officer |
|
2019-06-03 |
4 |
OE |
$52.02 |
$227,171 |
D/D |
4,367 |
122,250 |
|
- |
|
Pendarvis David |
Chief Administrative Officer |
|
2019-05-31 |
4 |
D |
$114.12 |
$27,275 |
D/D |
(239) |
117,883 |
|
- |
|
Sandercock Brett |
Chief Financial Officer |
|
2019-05-30 |
4 |
AS |
$112.34 |
$337,020 |
D/D |
(3,000) |
79,514 |
|
- |
|
Wareham John P |
Director |
|
2019-05-24 |
4 |
S |
$113.44 |
$5,048,725 |
D/D |
(44,342) |
13,000 |
|
- |
|
Wareham John P |
Director |
|
2019-05-24 |
4 |
OE |
$51.25 |
$2,290,722 |
D/D |
44,342 |
36,629 |
|
- |
|
De Witte Jan |
Director |
|
2019-05-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,406 |
|
- |
|
Douglas Robert Andrew |
President and COO ResMed Inc. |
|
2019-05-15 |
4 |
AS |
$111.35 |
$99,436 |
I/I |
(893) |
151,464 |
|
- |
|
1262 Records found
|
|
Page 23 of 51 |
|
|